Home LiteratureArticle Details
PMID: 23063122 Published · ppublish English

A structural basis for the assembly and functions of a viral polymer that inactivates multiple tumor suppressors.

Cell ·Vol. 151 ·No. 2 ·2012-12-28

Ou Horng D, Kwiatkowski Witek, Deerinck Thomas J, Noske Andrew, Blain Katie Y, Land Hannah S, Soria Conrado, Powers Colin J, May Andrew P, Shu Xiaokun, Tsien Roger Y, Fitzpatrick James A J, Long Jeff A, Ellisman Mark H, Choe Senyon, O'Shea Clodagh C

Abstract

Evolution of minimal DNA tumor virus' genomes has selected for small viral oncoproteins that hijack critical cellular protein interaction networks. The structural basis for the multiple and dominant functions of adenovirus oncoproteins has remained elusive. E4-ORF3 forms a nuclear polymer and simultaneously inactivates p53, PML, TRIM24, and MRE11/RAD50/NBS1 (MRN) tumor suppressors. We identify oligomerization mutants and solve the crystal structure of E4-ORF3. E4-ORF3 forms a dimer with a central β core, and its structure is unrelated to known polymers or oncogenes. E4-ORF3 dimer units coassemble through reciprocal and nonreciprocal exchanges of their C-terminal tails. This results in linear and branched oligomer chains that further assemble in variable arrangements to form a polymer network that partitions the nuclear volume. E4-ORF3 assembly creates avidity-driven interactions with PML and an emergent MRN binding interface. This reveals an elegant structural solution whereby a small protein forms a multivalent matrix that traps disparate tumor suppressors.

Article Info
Journal
Cell
Abbr.
Cell
Published
2012-12-28
Indexed
2012-10-15
Updated
2016-10-19
Language
English
Country/Region
United States
NLM ID
0413066
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com